Sarabhai family

Skyroot Aerospace completes Series A funding to become the most affordable on-demand ride to space on the planet

Retrieved on: 
Tuesday, July 6, 2021

The funding will be used to acquire new talent and complete the development of its Vikram-1 launch vehicle.

Key Points: 
  • The funding will be used to acquire new talent and complete the development of its Vikram-1 launch vehicle.
  • This disruptive cost efficiency gives their international customers a cheaper and unique option for on-demand and dedicated payloads.
  • Its core product, Vikram series named after the pioneer of India's space program Dr. Vikram Sarabhai has three rockets in development to launch small satellites.
  • Founded by former scientists of the Indian Space Research Organization (ISRO), Skyroot Aerospace is an national award-winning startup developing India's first privately built space launch vehicles.

Co-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five Diagnostic Assays

Retrieved on: 
Tuesday, December 3, 2019

The licenses and regulatory clearance allow CoSara for the first time to manufacture and sell the tests for the detection of the respective pathogens and microorganisms.

Key Points: 
  • The licenses and regulatory clearance allow CoSara for the first time to manufacture and sell the tests for the detection of the respective pathogens and microorganisms.
  • CoSara distributors have begun taking pre-orders for the five IVDs, and the Company expects sales to ramp quickly.
  • The JV has the exclusive manufacturing rights in India for the complete menu of Co-Diagnostics infectious disease molecular diagnostics kits, designed by Co-Diagnostics using their patented CoPrimer technology platform.
  • We are honored to be the manufacturer of the first indigenous PCR-based diagnostic kits in India, said Mr. Mohal Sarabhai, CEO of Synbiotics.

Co-Diagnostics, Inc. CEO Inaugurates Manufacturing Joint Venture Facility

Retrieved on: 
Tuesday, April 16, 2019

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the inauguration of its Indian joint venture facility for manufacturing in Ranoli, India.

Key Points: 
  • Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the inauguration of its Indian joint venture facility for manufacturing in Ranoli, India.
  • The facility was also designed to be in compliance with ISO 13485:2016, cGMP (Current Good Manufacturing Practices) regulations, and audits for WHO qualification and CE-marking of diagnostics products.
  • Mr. Dwight Egan, CEO of Co-Diagnostics Inc., and Mr. Mohal Sarabhai, CEO of Synbiotics Pvt Ltd, inaugurated the facility on April 8, 2019.
  • Mr. Sarabhai commented, CoSara brings cutting-edge molecular technology to India through this joint venture.